Loading...
XSHG
605016
, Last price  
Name

Shandong Bailong Chuangyuan Bio-Tech Co Ltd

Chart & performance

D1W1MN
XSHG:605016 chart
P/E
—
P/S
—
EPS
2.08
Vol. 1Y
—
Shs. 5Y
18.71%
Rev. 5Y
22.51%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.38b
+19.75%
335,524,100310,609,700355,534,000421,053,300499,624,282653,356,099721,893,633868,259,7291,151,652,2681,379,053,687
Net income
369m
+50.06%
64,798,50063,733,90065,304,40082,783,20095,552,198104,479,178150,751,366192,995,677245,598,463368,550,234
CFO
135m
-54.98%
60,100,400113,469,20089,119,80864,079,025121,820,41596,195,458149,815,201194,632,929300,892,601135,450,009
Dividend
Sep 29, 20260.075 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. specializes in the manufacturing and global distribution of functional carbohydrates. The company's diverse product range includes various categories: Oligosaccharides: Offered in both powdered and liquid forms, such as oligofructose, isomalto oligosaccharide, xylo-oligosaccharides, and galactooligosaccharides. Dietary Fibers: Featuring ingredients like polydextrose and resistant dextrin. Sugar Alcohols: Encompassing crystalline maltitol and maltitol syrup. Starch Sugars: Including high fructose syrup, maltodextrin, and high maltose powder. Specialty Syrups: Formulations tailored for applications like mono cake, bakery, and bread products. Fermentation Products: A separate category of offerings. Established in 2005, the enterprise maintains its headquarters in Yucheng, China.
IPO date
Apr 21, 2021
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
山东省德州(禹城)国家高新技术产业开发区德信大街
德州市, SD 251200
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT